Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Torisel + Letrozole in Advanced Breast Cancer
NCT00062751Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2002
- Primary completion
- Apr 2005
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of temsirolimus in breast cancer (3 arms), sponsored by Pfizer. Primary endpoint: Objective Response Rate. Started Dec 2002; status: completed.
02
Drugs
temsirolimus
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00062751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00062751.